Oragenics, Inc. OGEN

Full chart Compare
Set alert

Price alert · OGEN

All alert types
0.37 USD 0.00 (+0.51%)

At closeNov 4, 2026, 7:16 PM EST

0.38 +0.01 +2.12%

After hours · Nov 4, 7:16 PM ET

0.3702 Day range 0.3752
0.35 52-week range 1.22
YTD
-52.31%
1 year
-67.08%

Revenue & Expenses

Other Income → Expenses: $279.76KExpenses → Selling, General & Admin: $5.45MExpenses → Research & Development: $15.49MExpenses → Interest Expense: $30.59KGross Profit → Expenses: $37.65KRevenue → Gross Profit: $37.65KNet Loss → Expenses: $20.66MOther Income$279.76KGross Profit$37.65KNet Loss$20.66MExpenses$20.97MSelling, General & Admin$5.45MResearch & Development$15.49MInterest Expense$30.59KRevenue$37.65K

Latest period ending Dec 31, 2025 · select a line to chart its full history

OGEN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-9.36M-10.56M-20.90M-14.42M-15.77M
-9.84M-10.57M-20.66M-14.29M-15.71M
-4.56-47.88-275.00-213.00-243.00
OGEN annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
4.40M864.84K3.48M11.43M27.27M
10.07M1.47M4.97M14.76M28.23M
1.79M1.68M1.80M1.75M1.74M
227.35K328.53K322.51K624.53K797.21K
8.28M-211.88K3.17M13.01M26.49M
OGEN annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-9.25M-8.60M-7.29M-15.23M-13.47M
16.78M5.98M283.88K-494.92K23.14M
7.53M-2.62M-7.94M-15.84M9.63M